Original Articles :           

  1. Chakraborty DP, Chatterjee A Urinary indole profile of B. Melanostictus during hydroquinone induced leucoderma and its regenaration. Clin Chim. Acta 79, 399-400, 1977.

  2. Chakraborty DP, Chowdhury SKR, Dey RN, Chatterjee A Interrelationship of tryptophan pyrrolase in melanogenesis of B. Melanostictus  Clin. Chim Acta 82, 55- 59, 1978.

  3. Chakraborty AK, Chatterjee A, Chakraborty C, Chakraborty DP. Effect of tryptophan on tyrosinase in relation to vitiligo. Experientia 36, 920, 1980

  4. Chakraborty DP, Chatterjee A, Chakraborty AK, Chakraborty C. A method of bioassay of antivitiligo drugs Science and Culture, 47, 228-230.

  5. Chakraborty DP, Chatterjee A, Chakraborty AK Induced depigmentation in B. Melanostictus and ascorbic acid J. Ind. Chem. Soc LVIII, 608-610, 1981.

  6. Chatterjee A, S Ghosh, Das S, Sen S  Isolation of yeast ascospores free of vegetative cell contamination. J. Gen. Microbiol. 128,  2725-2728, 1982.

  7. Chakraborty C, Chatterjee A, Chakraborty AK, Chakraborty DP  Inverse relationship between melanogenesis and endogenous hydroquinone. Experientia 40, 829, 1984.

  8. Freeman JW, Chatterjee A, Busch H  Discrimination of epitope identified by monoclonal antibodies by competitive binding to nitrocellulose bound antigens. J. Immunol. Methods 78, 259- 265, 1985.

  9. Freeman JW,Chatterjee A, Ross B,  Busch H, Epitope discrimination and immunochemical charecterization of nucleolar phosphoprotein C23 using the monoclonal antibodies. Mol. & Cell. Biochem. 68, 87-96, 1985.

  10. Busch H, Busch RK, Chan PK, Chatterjee A,Freeman JW, Ross B, Black A, Yaneva M. Nucleolar antigens in cancer tissues, International Academy of Tumor Marker Oncology, 1, 69-80, 1986.

  11. Chatterjee A, Freeman JW and  Busch H, Development of panel of monoclonal antibodies  against HeLa nuclear and nucleolar antigens associated with cell proliferation. Am. Asson. Cancer Resh. Atlanta,  USA 1987.

  12. Chatterjee A, Freeman JW and Busch H,   Identification and partial charecterisation of a 40 kD nucleolar antigen associated with cell proliferation. Cancer Resh, 47, 1123-1129, 1987.

  13.  Busch H, Freeman JW, Busch RK, Chatterjee A, Black A. At last : meaningful and reproducible immunological distinctions between cancer cells and normal resting cells. Clinical Immunology News Letter 8, 17-20, 1987.

  14. Busch H, Busch RK, Black A, Chan PK, Chatterjee A, Durban E, Freeman JW, Ochs R, Tan EM, Ross B, Yaneva M. Novel nucleolar antigens in autoimmune diseases. J. Reumatol 14, 70-77, 1987.

  15. Chatterjee A, Freeman JW, Busch H Identification and partial charecterisation of a 105, 000 Mr nucleolar antigen associated with cell proliferation. Cancer Resh 47, 6329, 1987.

  16. Busch H, Busch Rk, Chan PK, Chatterjee A, Freeman JW, Ross B, Black A, Yaneva M.  Nucleolar antigens in cancer tissues. Human Tumor markers  Page  203-221,  1987.

  17. Busch H, Busch RK, Freeman JW, Black A, Rabinovsky E, Chatterjee A, Reddy AB, Yaneva M.  Nucleolar G antigens as cancer targets. J. Tumor Marker Oncol. 2, 141-151, 1987.

  18. Chatterjee A, Durban E, Busch H. Charecterisation of a nuclear antigen associated with cell proliferation. Cancer Resh. 48, 7159-7163,  1988.

  19. Reddy AB, Chatterjee A, Rothblum LI, Black A, Busch H. Isolation and charecterisation of a complementary DNA to proliferating cell nucleolar antigen P-40. Cancer Resh. 49, 1763-1767, 1989.

  20. Chatterjee A, Dutta K, Roychowdhury J. Identification of a novel 80 kD antigen associated to cell proliferation. Cancer Letter 47, 199-204, 1989.

  21. Chatterjee A, Busch RK, Zung D, Zahang WW, Busch H, Purification of a group of HeLa nuclear proteins that binds to a proliferating cell nuclear protein P 120 gene. Biochem Biophys Res Commun. 180, 805-815,  1991.

  22. Chatterjee A, Biswas N, Chowdhury S, Roychowdhury J. Idewntification of a 60 kD antigen associated malignant growth of human breast tissue. Oncology 53, 422-425, 1996.

  23.  Chatterjee A. Integrins- New Frontier in Cancer Biology. Ind. Jour. Exp. Resh. 34, 923-926,  1996

  24. Chowdhury SK and Chatterjee A. Reversal of resistance against doxorubicin by a newly developed compound, Oxalibis( N-Phenyl)hydroxamic acid in vitro. Anti Cancer Drug, 9, 825- 832, 1998.

  25. Sengupta S, Ray S, Chattopadhyay N, Biswas N, Chatterjee A. Effect of AllTrans Retinoic acid on metastatic potential of B16F10 cells. J.Exp. Clin. Cancer Resh. 19. No-1, 81-88, 2000.

  26. Ray S, Chattopadhyay N, Biswas N, Chatterjee A. Regulatory moleculas in tumor metastasis. J. Env.Pathol. Toxicol. Oncol 18, No-9, 251-259,1999.

  27. Chattopadhyay N, Ray S, Biswas N, Chatterjee A Effect of All Trans Retinoic Acid  on Integrin receptors of cervical cancer cells(SiHa) Gyn. Oncol 75, 215-221, 1999.

  28. Chattopadhyay N, Chatterjee A. Studies on the expression of alfaVbeta3 integrin receptor in non malignant and malignant human cervical  tumor tissue  J.Exp. Clin. Cancer Resh,20, no-2,269-275,  2001

  29. Chattopadhyay N, Chatterjee A. Role of alfaVbeta3 integrin receptor in the invasive potential of cervical cancer cells. J. Env.Toxicol.Pathol. Oncol 20, no-4,211-221, 2001.

  30. Ray S, Chattopadhyay N, Sanyal U, Biswas N, Chatterjee A. Integrin Modulating Factor: A 30 kD protein that modulates the activity of alfa5beta1 integrin receptor in cervical cancer cells. J. Env. Toxicol. Pathol. Oncol. 20, no-4,199-209 2001.

  31. Sengupta S, Chattopadhyay N, Ray S, Mitra A, Dasgupta S, Chatterjee A. Role of alfaVbeta3 integrin receptor in breast tumor J. Exp. Clin. Cancer Resh. 20,no-4,203-208, 2001

  32. Chattopadhyay N, Mitra A, Frei E , Chatterjee A AlfaVbeta3 Integrin receptor expressed on human cervical cell (SiHa) surface has associated matrixmetalloproteinase activity. J. Cancer Resh. Clin. Oncol,127, 653-658, 2001

  33. Ray S, Chattopadhyay N, Siddiqi M, Mitra A, Chatterjee A Curcumin exhibits antimetastatic properties by modulating Integrin receptors ,collagenase activity, and expression of Nm 23 and E-cadherin. J. Env. Pathol.Toxicol.Oncol. 21, no4, 347-354, 2002   
                        
  34. Mitra  A, Chakraborty J, Chattopadhyay N, Chatterjee A. Studies on membrane associated MMP2 in human cervical tumor . J.Env.Pathol.Toxicol.Oncol , vol-22, no-2,  2003.

  35. Mitra A,Chakraborty J,Chatterjee A. Ligation of a5b1 integrin by alfa5 monoclonal antibody modulates expression and activity of MMP2 & MMP7 in B16F10  melamona cells . J. Env. Pathol. Toxicol.Oncol, Vol-22 (3), 167-178,  2003.

  36. Banerji. A, Chakraborti, J, Mitra. A, Chatterjee. A Effect of Curcumin on Gelatinase A ( MMP-2) in B16F10 cells  Cancer. Lett.  Vol-211, no-2, 235-242, 2004.

  37. Mitra.A, Chakraborti.J, Banerji.A,Chatterjee.A Binding of alfa2 monoclonal antibody to alfa2 beta1 Integrin activates GlatinaseA( MMP2) in human cervical tumor cells( SiHa ) Gynae. Oncol vol-94, no-1, 33-39, 2004.

  38. Banerji A, Chakraborti J, Mitra A, Chatterjee A  Cell membrane associated MT1-MMP dependent activation of  proMMP-2 in A375 melanoma cells. Jour. Env. Pathol. Toxicol. Oncol. Vol 24(1), 1-16, 2005.



  39. Evelyn Y-L. Kim, Claas Gronewold Amitava Chatterjee,  Claus- Wilhelm von der Lieth, Christian Kliem, Lutz Langbein, Birgit Schmauser, Manfred Wiessler, Eva Frei. Saccharide mimetics containing galactose and fucose specifically label tumor cell surface and inhibit cell adhesion to fibronectin.  Chem  Bio  Chem, vol-6, 1- 10, 2005.

  40. Mitra. A, Chakraborty. mediated MT1-MMP dependent activation of Gelatinase A(MMP-2) in human cervical tumor cell(SiHa). J.Env.Pathol.Toxicol.Oncol , v-25, no-4,655-666, 2006.

  41. Chakraborti.J,Mitra.A, Banerji A and Chatterjee.A  Culture of HT-1080 cells in presence of fibronectin activates MMP-2,  Jour.Env.Toxicol.Pathol.Oncol v-25,n0-4,667-677,2006.

  42. Mitra A, Chakrabarti J, Bannerji. A, Das S and Chatterjee A   Culture of SiHa cells in presence of fibronectin in serum free culture medium activates MMP-2. Jour. Can. Resh. Clin. Oncol , v-132,505-513,2006.

  43. Mitra A, Chakraborti J, Banerji A, Chatterjee A, B R Das   Curcumin a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells  J. Env. Pathol. Toxicol. Oncol.  J.Env.Pathol.Toxicol.Oncol, v-25,n0-4,679-689, 2006.

  44. Das  S , Bannerji A, Frei A and  Chatterjee A   Culture of MCF-7 human breast cancer cells in serum free medium in presence of fibronectin activates MMP-2 and MMP-9,  Life  Sciences  vol-82,467-476, 2008

  45. Ashok K Chakrabortya, Josane de Frietas Sousa, Debjit Chakraborty, Yoko Funasaka, Mahasweta Bhattacharyaa, Amitava Chatterjee, John Pawelek, GnT-III, a GnT-V Antagonist, Suppresses Melanogenesis  and    Motility in Macrophage-Melanoma Fusion Hybrids,   , GENEv-334, 166-173, 2006


  46. Mitra A, Chakraborty J, Bannerji A, Das S, Chatterjee A. Integrin -MMP Interrelation. A potential area to develop anti metastatic drugs-  Treands  in Pharmacology, edited by Roy & Gulati Chapter 26.  2006.


  47. Maity G, Mandal S, Chatterjee A, Bhattacharrya D. Purification & Characterization of a low molecular cytotoxic phospholipase A2 from Russel’s viper venom : A multifunctional protein. Jour. Chromato. B,v-845, 232- 243, 2007.


  48. Moulik S, Chatterjee A. Vascular endothelial growth factor (VEGF) & tumour angiogenesis. Indian J Med Res 125(6):715-6 (2007) PMID 17704546.

  49. Das S, Banerji A, Frei E, Chatterjee A. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci. 2008 Feb 27;82(9-10):467-76.

  50. Moullick S, Sen T, Dutta A, Ghosh C, Bannerji A, Das S,Chatterjee A. Phosphatidylinositol 3-Kinase and NF-κB Involved in Epidermal Growth Factor-Induced Matrix Metalloproteinase-9 Expression. Jour .Cancer Mols. Vol-4(2),55-60, 2008.


  51. Banerji A, Chatterjee A. Culture of A-375 cancer cells on fibronectin coated plates activates MMP-2 and MMP-9, Jour. Toxicol. Pathol. Oncol, vol-27(2), 135-145, 2008 .

  52. Sen T, Moullick S, Roychowdhury P, Dutta A, Banerji A, Das S, Chatterjee A. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sciences vol-84,194-204, 2009.

  53. Dutta A, Sen T, Banerji A, Das S, Chatterjee A. Studies on  Multifunctional Effect of All-Trans Retinoic Acid (ATRA) on Matrix Metalloproteinase-2 (MMP-2) and Its Regulatory Molecules in Human Breast Cancer Cells (MCF-7). Journal of Oncology, Volume 2009,1- 12.

  54. Maity G, Fahreen S, Banerji A, Sen T, Dutta A, Roychowdhury P, Chatterjee A. Fn-Integrin mediated signaling in human cervical cancer cells (SiHa), Mol Cell Biochem vol-336,(1-2), 65-74, 2010.

  55. Dutta A, Sen T, Chatterjee A. Culture of K562 human myeloid leukemia cells in presence of fibronectin expresses and secretes MMP-9 in serum free culture medium. International Jour of Exp Clin Pathol, vol-3(3), 288-302, 2010

  56. Sil H, Sen T, Moulick S, Chatterjee A.  Black Tea Polyphenol (Thea?  avin) Downregu- lates MMP-2 in Human Melanoma Cell Line  A375 by Involving Multiple Regulatory Molecules.  Jour Env Patho toxicol Oncolvol-29(1) 55-68, 2010.

  57. Sen T, Dutta A, Maity G, Chatterjee A. Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways. Biochimie.Volume 92, Issue 10, October 2010, 1422-1434.

  58. Sen T, Dutta A, Chatterjee A, EGCG downregulates Gelatinase-B (MMP-9) by involvement of FAK/ERK, NF-kB and AP-I in the human breast cancer cell line MDA-MB-231.  Anti Cancer Drugs vol-21 (6), 632-644, 2010.

  59. Dutta A, Sen T, Chatterjee A. All-trans retinoic acid (ATRA) downregulates MMP-9 by modulating its regulatory molecules. Cell Adh Migr. 2010 Jul-Sep; 4(3):409-18.

  60. Sen T, Chatterjee A. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process. Eur J Nutr. 2011 Sep; 50(6):465-78.

  61. Maity G, Choudhury P R, Sen T, Ganguly K K, Sil H, Chatterjee A. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity. Tumour Biol. 2011 Feb; 32(1):129-38.

  62. Maity G, Sen T, Chatterjee A. Laminin induces matrix metalloproteinase-9 expression and activation in human cervical cancer cell line (SiHa). J Cancer Res Clin Oncol (2011) 137:347–357.

  63. Sil H, Sen T, Chatterjee A. Fibronectin – Integrin (α5β1) modulates migration and invasion of murine melanoma cell line B16F10 by involving MMP-9, Oncology Research, vol 19, 2011, 335-348.

  64. Pal S, Ganguly K K, Moulik S, Chatterjee A. Modulation of MMPs by cell surface integrin receptor α5β1. (Accepted for publication in Anti-cancer Agents in Medical Chemistry., September, 2011)

  65. Ganguly K K, Sen T, Pal S, Biswas J, Chatterjee A. Studies on Focal Adhesion Kinase in Human Breast Cancer cell MDA-MB-231. (Accepted for publication in Advances in Biological Chemistry, Nov, 2011).

  66. Ganguly K K, Sen T, Mandal S, Biswas J, Chatterjee A. Studies on Focal Adhesion Kinase in Human Breast Cancer Tissue.(Accepted for publication in Journal of Cancer Therapy, Dec, 2011).

  67. Kirat Ganguly, Sekhar Pal, Amitava  Chatterjee,  Integrin and Metastasis, Cell Migration and Adhesion (accepted for publication, Jan 2013).

  68. Sil H, Chatterjee A et al, MMP-2 in breast cancerJEPTO (communicated  Jan 2013.

  69. Sil H, Chatterjee A et al  MMP-9 in human breast cancer, Breast JEPTO (Communicated,  Feb 2013.)

  70. ERK in breast cancer-  Moulik  S  A  Chatterjee  et  al  -  Jour  Tumor  2014.
  71. MMP-2  -  Sil  H, A Chatterjee  et al     Jour  Tumor     2015.( in press)

  72. Extracellular matrix- Integrin crosstalk modulates MMP-1 in breast cancer- Sekhar Pal, A Chatterjee- Jour Of Tumor, 2015 (accepted for publication)

  73. alfaVbeta3 integrin associated MMP-2 in breast cancer. Sil H, Chatterjee A Jour Tumor (communicated, 2015).
  74.  


 
Amitava Chatterjee. 
Ph.D.


E mail:
info@darwin-newton.com

 


  

   
           

Dr. Amitava Chatterjee. All rights reserved
Site Designed by Bangalinet

   

My Biographical  Informations My Original Articles Contact Me